Jeffrey Glenn Net Worth & Insider Trades
Jeffrey Glenn Eiger Biopharmaceuticals, Inc
What is Jeffrey Glenn's Net Worth?
The current estimated net worth of Eiger Biopharmaceuticals, Inc's Jeffrey Glenn is estimated to be about $225.04K . Jeffrey Glenn owns about 156,064 units of Eiger Biopharmaceuticals, Inc common stock. In the last 6 years at Eiger Biopharmaceuticals, Inc, Jeffrey Glenn has sold an estimated value of $0 worth.
What is Jeffrey Glenn's Past Insider Trading?
Jeffrey Glenn's largest purchase order was 15,460 units , worth over $196.88K on November 21, 2016. In total, Jeffrey Glenn has made about 11 transactions over 6 years of their time at Eiger Biopharmaceuticals, Inc. Jeffrey Glenn usually trades in March, with the busiest year in 2020. The most recent transaction was a purchase order of 10,000 units , worth over $114.57K on August 12, 2020.
Jeffrey Glenn
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Jeffrey Glenn's' Mailing Address?
- Mailing address is 350 Cambridge Avenue, Suite 350 Palo Alto CA 94306 CA
Eiger Biopharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| David A. Cory | 2020 | $590,584 | - | - | $829,564 | $393,360 | $16,671 | $1,830,179 |
| David A. Cory | 2019 | $565,833 | - | - | $2,009,820 | $285,000 | $11,200 | $2,871,853 |
| Sriram Ryali | 2020 | $381,550 | - | - | $234,442 | $173,272 | $12,296 | $801,559 |
| Sriram Ryali | 2019 | $335,000 | - | - | $662,211 | $117,250 | $9,732 | $1,124,193 |
| Eldon Mayer | 2020 | $385,569 | $100,000 | $92,700 | $1,199,520 | $169,256 | $2,328 | $1,949,373 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm
What are Eiger Biopharmaceuticals, Inc's Past Insider Trades?
Eiger Biopharmaceuticals, Inc's most recent insider trade came on August 18, 2022 by David Apelian who sold 5,000 units worth $49.03K . In the last 6 years, insiders at Eiger Biopharmaceuticals, Inc have sold an estimated value of $3.02M and bought an estimated value of $4.61M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are John Thomas Dietz, Eldon Mayer III, Ex VP & Chief Commerc. Officer, and David Cory, President and CEO .
Eiger BioPharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||